Chemopreventive and bioenergetic signaling effects of PDK1/Akt pathway inhibition in a transgenic mouse model of prostate cancer. (Q53547402)

15 May 2018

title

Chemopreventive and bioenergetic signaling effects of PDK1/Akt pathway inhibition in a transgenic mouse model of prostate cancer. (English)

1 reference

15 May 2018

author name string

Aaron M Sargeant

1

1 reference

15 May 2018

Russell D Klein

2

1 reference

15 May 2018

Robert C Rengel

3

1 reference

15 May 2018

Steven K Clinton

4

1 reference

15 May 2018

Samuel K Kulp

5

1 reference

15 May 2018

Yoko Kashida

6

1 reference

15 May 2018

Mamoru Yamaguchi

7

1 reference

15 May 2018

Xingya Wang

8

1 reference

15 May 2018

Ching-Shih Chen

9

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 June 2007

1 reference

15 May 2018

published in

Toxicologic Pathology

1 reference

15 May 2018

volume

35

1 reference

15 May 2018

issue

4

1 reference

15 May 2018

page(s)

549-561

1 reference

15 May 2018

Mouse models of prostate carcinogenesis.

cites work

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Genetically engineered animals in drug discovery and development: a maturing resource for toxicologic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Akt stimulates aerobic glycolysis in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Prostate cancer in a transgenic mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

A novel celecoxib derivative, OSU03012, induces cytotoxicity in primary CLL cells and transformed B-cell lymphoma cell line via a caspase- and Bcl-2-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

7-hydroxystaurosporine (UCN-01) inhibition of Akt Thr308 but not Ser473 phosphorylation: a basis for decreased insulin-stimulated glucose transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

3-phosphoinositide-dependent protein kinase-1/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Essential role of PDK1 in regulating cell size and development in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

The emerging role of the PI3-K-Akt pathway in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

OSU-03012 in the treatment of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Glycogen synthase localization and activity in rat skeletal muscle is strongly dependent on glycogen content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Glucose metabolism in mice lacking muscle glycogen synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Akt-dependent transformation: there is more to growth than just surviving

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Prognostic significance of activated AKT expression in soft-tissue sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/01926230701338966

10.1080/01926230701338966

21 January 2018

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018